United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read Pharma Industry News Capricor Therapeutics advances deramiocel toward FDA approval with priority review Capricor Therapeutics has reached a significant milestone in its efforts to develop a novel treatment for Duchenne muscular… byPallavi MadhirajuMarch 11, 2025